pathios therapeutics
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
pathios therapeutics has raised €8.1M across 1 funding round, most recently a Series A round in Oct 2019. Based in Oxford, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€8.1M
€8,081,550
Funding rounds
1
Investors
0
distinct backers
Active since
2019-10
latest 2019-10
Funding by year
EUR raised per yearpathios therapeutics — funding by year — interactive chart.
Data table
| pathios therapeutics — funding by year | |
|---|---|
| 2019 | €8.1M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series A | €8.1M | — | View deal → |